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SHORT REPORT
The effect of genome-wide association scan quality
control on imputation outcome for common variants
Lorraine Southam1, Kalliope Panoutsopoulou2, N William Rayner3,4, Kay Chapman1, Caroline Durrant3,
Teresa Ferreira3, Nigel Arden5,6, Andrew Carr1, Panos Deloukas2, Michael Doherty7, John Loughlin8,
Andrew McCaskie8,9, William ER Ollier10, Stuart Ralston11, Timothy D Spector12, Ana M Valdes12,
Gillian AWallis13, J Mark Wilkinson14,15, the arcOGEN consortium, Jonathan Marchini16 and Eleftheria Zeggini*,2
Imputation is an extremely valuable tool in conducting and synthesising genome-wide association studies (GWASs). Directly
typed SNP quality control (QC) is thought to affect imputation quality. It is, therefore, common practise to use quality-controlled
(QCed) data as an input for imputing genotypes. This study aims to determine the effect of commonly applied QC steps on
imputation outcomes. We performed several iterations of imputing SNPs across chromosome 22 in a dataset consisting of
3177 samples with Illumina 610k (Illumina, San Diego, CA, USA) GWAS data, applying different QC steps each time. The imputed
genotypes were compared with the directly typed genotypes. In addition, we investigated the correlation between alternatively QCed
data. We also applied a series of post-imputation QC steps balancing elimination of poorly imputed SNPs and information loss. We
found that the difference between the unQCed data and the fully QCed data on imputation outcome was minimal. Our study shows
that imputation of common variants is generally very accurate and robust to GWAS QC, which is not a major factor affecting
imputation outcome. A minority of common-frequency SNPs with particular properties cannot be accurately imputed regardless of
QC stringency. These findings may not generalise to the imputation of low frequency and rare variants.
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INTRODUCTION
Genome-wide association scans (GWASs) have proven to be a
successful strategy for detecting common variants exerting modest
effects on complex disease risk. Currently available commercial
platforms focus on common variants and capture the majority
of HapMap1 SNPs with minor allele frequency (MAF) 40.05 in
European populations.2 Several large-scale consortia have been formed
in order to carry out GWAS meta-analyses for various phenotypes,
with successful outcome (eg, Zeggini et al,3 Prokopenko et al,4 Franke
et al,5 Barret et al6 and Soranzo et al7). To enable the combination
of data across studies carried out on different platforms, and to enable
in silico fine mapping of association signals, imputation approaches
were proposed a few years ago8 as a means of statistically inferring
genotypes at untyped loci using a reference set, for example, the
HapMap (B2 500 000 SNPs).
An important aspect of any GWAS analysis is the implementation
of a series of rigorous quality control (QC) steps before testing for
association. These QC procedures help guard against genotyping error,
population stratification, sample duplication and other confounders
that can affect the analysis results. QC steps are typically applied at the
sample- and SNP-specific level. Sample-level QC includes filtering out
samples with low call rates, evidence for different ethnic origin, high
heterozygosity, relatedness/duplication, gender discrepancies and
genotyping batch effects. SNP-level QC includes filtering out SNPs
with low call rates and deviation from Hardy–Weinberg equilibrium
(HWE) at pre-determined thresholds. It is generally believed that
datasets should be stringently quality controlled (QCed) at the marker
level before applying imputation approaches. For this reason, lower
MAF SNPs tend to also be excluded, as their accuracy can be
hampered by poor clustering properties and incorrect automated
genotype calling (at least with currently widely used algorithms).
Even though such weight is placed on pre-imputation SNP QC,
the effects of applying different criteria and thresholds to the starting
dataset have not been investigated thus far. In this report, we evaluate
the effect of GWAS QC on imputation outcome, and find that
imputation works very well for common variants irrespective of QC,
and that a minority of some common-frequency SNPs with particular
properties cannot be accurately imputed regardless of QC stringency.
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MATERIALS AND METHODS
We used an empirical GWAS dataset to assess the effect of QC on imputation
outcome. We focused on chromosome 22, (n¼9038 directly typed SNPs) from
3177 osteoarthritis (OA) cases from the United Kingdom, typed on the
Illumina 610k quad chip (Illumina) as part of the arcOGEN consortium
GWAS (manuscript submitted). Chromosome 22 is representative of the
genome in terms of the proportion of directly typed to imputed SNPs.
All samples included in our analysis had passed standard sample level QC
(based on call rate, heterozygosity, relatedness, ethnicity and gender discre-
pancies). We imputed genotypes at variants on the basis of HapMap phase II
release 22 CEU data (n¼33 815 SNPs on chr22) using IMPUTE v1 (https://
mathgen.stats.ox.ac.uk/impute/impute.html).8
We performed each imputation in duplicate, with and without the IMPUTE v1
predict genotyped SNPs flag, which resulted in one set of imputed data
containing the original genotypes and in the other imputed genotypes.
To assess the effect of varying levels of QC, we carried out several rounds of
imputation, using differently QCed OA SNP data as the starting point.
Initially, we imputed on the basis of no SNP-level QC, including all directly
typed SNPs, regardless of MAF, call rate and HWE. We also imputed on the
basis of only those SNPs that passed stringent QC thresholds (call rate495%
for SNPs with a MAF Z5% and call rate499% for SNPs with a MAFo5%,
HWE exact P40.0001, MAF 40.01 and removing all SNPs with GC or TA
alleles; Table 1). Although imputation biases can occur due to poor clustering
of SNPs with miscalled genotypes in the starting dataset, cluster plot checking is
not feasible at the genome-wide scale and therefore, it is not implemented
in standard GWAS QC.
We evaluated the accuracy of imputed genotypes by comparing allele
frequencies at the same SNP between imputed and true, directly typed data.
For each QC-imputation iteration, we performed an allele frequency compar-
ison between the actual directly typed and imputed SNPs. Under perfect
imputation, we would expect to see alignment with the null hypothesis of no
association. We used SNPTEST (http://www.stats.ox.ac.uk/~marchini/software/
gwas/snptest.html)9 to investigate differences between directly typed and
imputed genotypes at the same variants within the same samples, taking into
account the distribution of genotype probabilities for each individual. For the
purposes of our comparison, we used those SNPs that were directly genotyped
in OA cases and also present in the HapMap reference samples. Table 1
summarises the number of these SNPs for each QC threshold.
When comparing directly typed with imputed allele frequencies at the same
variant in the same individuals, we arbitrarily considered Po106 as signifi-
cantly different. We calculated the correlation between imputed and directly
typed MAF, using the expected counts to allow for genotype-associated
probabilities. We also applied a series of post-imputation QC steps in order
to eliminate unreliably imputed SNPs, aiming to filter out as many of these
SNPs as possible while retaining a good proportion of nonsignificant SNPs.
We compared two alternative methods for post-imputation QC filtering, first,
the IMPUTE-info score, which is associated with the imputed allele frequency
estimate which ranges from 1, indicating high confidence, to 0 suggesting
decreased confidence, and second, the freq-add-proper-info score provided by
SNPTEST, a relative statistical score ranging from 0 to 1, representing no
information to complete information, respectively. The SNPTEST freq-add-
proper-info score has been shown to be highly correlated with the IMPUTE-info
score under the additive model.10 In both scenarios, we also filtered out SNPs
with MAFo5%. Figure 1 illustrates the effects of altering post-imputation QC
filters on the QCed data. On the basis of these results, we chose to use the
IMPUTE-info score with a filtering threshold o0.8 and MAF o5%, which
effectively eliminated B79% of the significant SNPs while retaining B85% of
the nonsignificant ones (SNPTEST freq-add-proper-info o0.9 and MAF 5%
would be roughly equivalent to this eliminatingB73% of the significant SNPs
while retaining B89% of the nonsignificant ones). We applied this post-
imputation filter to each of our datasets and compared the results. We looked
at the unQCed and QCed datasets first, as synopsised in Table 1. For each
scenario, we examined frequency differences between the directly typed and the
imputed genotypes as described above. In addition, we compared the imputed
genotypes at imputed SNPs only for the unQCed and the fully QCed (QCed
data with all poorly clustered markers removed) strategies.
RESULTS
Table 1 summarises the number of SNPs with significantly (Po106)
different allele frequencies between the directly typed and imputed data
in the same set of individuals for each of the different QC sets.
Correlation plots and R2 values for the comparisons of the QCed and
unQCed datasets are presented in Figure 2. The difference between the
unQCed (R2¼0.993) and QCed data (R2¼0.994) was minimal. After
post-imputation filtering there were 77 SNPs with significantly different
(imputed v. directly typed) allele frequencies in the unQCed data
compared with 67 significant SNPs in the QCed data. In an attempt
to improve imputation for the small subset of poorly imputed SNPs in
the QCed data, we excluded all SNPs with MAFo5% and, subsequently,
also SNPs with MAFo10%. We found that eliminating these lower
MAF SNPs before imputation had little effect overall. The R2 for the
post-imputation QC filtered comparison with the QCed data was
virtually identical both when excluding all SNPs with MAFo5%
(R2¼0.994) and when excluding all SNPs with MAFo10% (R2¼0.991).
Given this apparent minimal influence of input data QC on
imputation outcome, we investigated further the small set of SNPs
showing significant allele frequency differences for the presence
of a common characteristic that could conceivably be used as a
Table 1 Summary of QC steps and related SNP number breakdown
Post-imputation
unfiltered SNPs
Post-imputation
QC filtered SNPs a
Pre-impute QC threshold applied
Directly typed SNPs also
present in HapMap NS S NS S
None (‘unQCed’ dataset) 8064b 7689 375 6498 77
Typical GWAS QC (‘QCed’ dataset)c 7910 7585 325 6446 67
As above plus 14 significant SNPs removed with poor cluster plotsd 7896 7592 304 6449 61
As above plus 36 additional SNPs removed with poor cluster plotse 7860 7557 303 6419 58
Typical GWAS QC plus MAF o5%c 7554 7269 285 6434 65
Typical GWAS QC plus MAF o10%c 6544 6287 257 5569 53
Abbreviations: GWAS, genome-wide association study; MAF, minor allele frequency; NS, not significant; QC, quality control; QCed, quality controlled; S, significant.
aFiltering is based on removal of SNPs with an IMPUTE-info score of o0.8 and MAF o5%.
bThere were 8082 SNPs in the unQCed data, of which 18 were monomorphic in the arcOGEN cases but polymorphic in HapMap; these SNPs were removed by IMPUTE.
cTypical GWAS QC was MAF r5% with call rate o95% and MAF o5% with call rate o99%, Hardy–Weinberg equilibrium Po1104, and exclusion of GC and AT allele SNPs and MAF o1%
SNPs, applied as an additional post-association analysis and pre-imputation QC step.
dSignificant SNPs with poor cluster plots removed.
eThose SNPs flanking the significant SNPs with poor cluster plots removed.
arcOGEN data for chromosome 22 detailing the different pre-imputation QC steps. A breakdown of the SNP number for each QC threshold is indicated both with and without the post-imputation QC.
NS, PZ1106; significant SNPs, Po1106.
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post-imputation filter. To rule out poor genotyping as the cause of
these significant differences, we examined all cluster plots for the
unfiltered significant SNPs (Po1106, n¼325). In all, 14 poorly
clustered SNPs were removed and the data were re-imputed. After
post-imputation QC, three additional SNPs were not significant and
six were less significant. We then inspected the cluster plots for
10 SNPs on either side of the 61 SNPs remaining significantly different
to rule out poor imputation due to flanking SNP poor clustering
properties. We examined the cluster plots for 1008 SNPs and found
that 36 of these were poor; these resided in the proximity of 35 of
the significant SNPs. We subsequently removed these SNPs and
re-imputed. We found that following post-imputation QC filtering,
only 3 of the 61 SNPs were no longer significant, and the R2 remained
the same as for the QCed data (R2¼0.994) for the post-imputation
QC filtered data. When we repeated comparisons using IMPUTE v2
with the HapMap3 (CEU, release no. 2 February 2009) and data from
the 1000 genomes project (Pilot 1 genotypes released March 2010;
phased haplotypes released June 2010) as the reference panels, we
observed qualitatively similar results.
Differences in region-specific recombination rates may account for
the few remaining significant SNPs, as variants in areas of especially
high recombination rate may be more challenging to impute
accurately regardless of QC. To investigate this, we first examined
the QCed unfiltered data and found that when the data were
dichotomised into those markers with lower (o1 cm/Mb) and higher
(Z1 cM/Mb) recombination rates, there were more significant
SNPs present in the higher recombination rate group compared
with the lower recombination group (P¼1.851027, average recom-
bination rates of 12.8 and 3.04, respectively). When we examined the
QCed data post-imputation QC, this difference disappeared
(P¼0.526). This clearly indicates that application of the post-imputa-
tion QC filter successfully identifies the majority of significant SNPs
with high recombination rates. Therefore, to include recombination
rate as an extra filter would not be prudent, for example,
using the QCed post-imputation QC filtered data and applying a
further filter using a recombination rate threshold of 41 cM/Mb
would eliminate 2075 SNPs, only 24 of which are significantly
different.
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Figure 1 (a) Imputation results for the QCed data indicating the total number of SNPs filtered for different QC thresholds using the IMPUTE-info and freq-
add-proper-info scores. The SNPs remaining after the filter (red bar) have been subdivided into SNPs that are significant (green bar) and not significant
(yellow bar). (b) The same data as percentage of significant and nonsignificant SNPs removed for each threshold. Both methods of filtering appear to be
equivalent, but the freq-add-proper-info is shifted to the right for the same numerical threshold; we chose the IMPUTE-info o0.8 for further analysis (similar
to a freq-add-proper-info o0.9).
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DISCUSSION
The imputation accuracy of common variants does not appear to be
substantially affected by GWAS QC steps. Our data demonstrate that
there is little difference in imputation accuracy observed in unQCed
GWAS data when compared with QCed GWAS data. Furthermore,
the implementation of additional QC steps (eg, filtering out variants
with MAFo0.05 and o0.10) does not considerably improve overall
imputation accuracy. Missing variants and directly typed variants that
fail pre-imputation QC checks are imputed and these data are used for
downstream analyses. Post-imputation QC successfully eliminates a
good proportion of inaccurately imputed SNPs. Specifically, by apply-
ing a very stringent post-imputation QC threshold, a smaller set of
variants with more accurately predicted genotypes remain. The
IMPUTE-info threshold ofo0.8 and MAFr5% criterion successfully
filtered out the majority of poorly imputed SNPs. However, the
application of these strict filters in GWAS data could result in many
SNPs being excluded from the data, and thus potential true association
signals could be missed. Some of the inaccurately imputed variants were
due to poor clustering properties. It is plausible that the handful of
variants that still remained inaccurately imputed could be because
of the differences in ethnicity between our data and the HapMap CEU
reference panel from which the genotypes were predicted. We have used
IMPUTE, but do not expect our results and conclusions to qualitatively
differ with different imputation methods, for example, BEAGLE and
MACH exhibit similar imputation accuracy to IMPUTE.11 Differences
in population structure between the reference panel and target dataset
can be a source of imputation inaccuracy. Imputation accuracy for
common SNPs may be further increased by using larger reference
panels with data on denser sets of variants. Our results show that GWAS
QC is not of paramount importance for the imputation of common
variants. This may be different for the imputation of low frequency
and rare variants based on emerging reference panels such as the
1000 genomes (http://www.1000genomes.org) and UK10k (http://
www.uk10k.org) projects. In summary, our study demonstrates that
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Figure 2 Correlation plots and the associated R2 for (a) The unQCed and the QCed with and without post-imputation QC filtering (IMPUTE-info o0.8 and
MAF o5%). (b) The imputed-only markers in the unQCed and fully QCed data (QCed data with all poorly clustered markers removed) without
post-imputation QC filtering.
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imputation of common variants is generally very accurate and robust to
GWAS QC, which is not a major factor affecting imputation outcome.
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